Skip to main content
. 2022 Feb 20;14(2):e22402. doi: 10.7759/cureus.22402

Figure 5. Placement sites for RFID included in our study.

Figure 5

Mass: RFID placed into or adjacent to the ultrasound mass abnormality. Hematoma: RFID placed within a post-stereotactic biopsy hematoma. Lymph node: RFID used for localising the target lymph node.

RFID: radio-frequency identifier device